General Information of DTT (ID: TTPRDH7)

DTT Name Integrin alpha-V/beta-5 (ITGAV/B5) DTT Info
Gene Name ITGAV-ITGB5

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Discontinued Drug(s)
2 Discontinued Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
SB-267268 DMIBFAV Osteoporosis FB83.0 Discontinued in Phase 1 [1]
PS-388023 DM8P05S Ocular disease 1F00.1Z Terminated [2]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity. Invest Ophthalmol Vis Sci. 2006 Apr;47(4):1600-5.
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.